Research & Literature

Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.

Berlowitz DJ, Howard ME, Fiore JF, et al.

Journal of neurology, neurosurgery, and psychiatry 2016; (87(3)):280-6 doi:10.1136/jnnp-2014-310055.

Neuropsychological investigation in Chinese patients with progressive muscular atrophy.

Cui B, Cui L, Liu M, et al.

PloS one 2015; (10(6)):e0128883 doi:10.1371/journal.pone.0128883.

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

Russ KB, Phillips MC, Wilcox CM, Peter S

The American journal of the medical sciences 2015; (350(2)):95-7 doi:10.1097/MAJ.0000000000000517.

Advance care planning in motor neuron disease: A systematic review.

Murray L, Butow PN

Palliative & supportive care 2016; (14(4)):411-32 doi:10.1017/S1478951515001066.

Progressive Muscular Atrophy.

Liewluck T, Saperstein DS

Neurologic clinics 2015; (33(4)):761-73.

Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Saberi S, Stauffer JE, Schulte DJ, Ravits J

Neurologic clinics 2015; (33(4)):855-76.

Experiences and reflections of patients with motor neuron disease on breaking the news in a two-tiered appointment: a qualitative study.

Seeber AA, Pols AJ, Hijdra A, et al.

BMJ supportive & palliative care 2019; (9(1)):e8 doi:10.1136/bmjspcare-2015-000977.

Advance care planning in motor neuron disease: A qualitative study of caregiver perspectives.

Murray L, Butow PN, White K, et al.

Palliative medicine 2016; (30(5)):471-8 doi:10.1177/0269216315613902.

Unilateral progressive muscular atrophy with fast symptoms progression.

Bogucki A, Pigońska J, Szadkowska I, Gajos A

Neurologia i neurochirurgia polska 2016; (50(1)):52-4.

Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?

Prell T, Ringer TM, Wullenkord K, et al.

Journal of neurology, neurosurgery, and psychiatry 2016; (87(9)):1022-6 doi:10.1136/jnnp-2015-312185.

Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.

Talman P, Duong T, Vucic S, et al.

BMJ open 2016; (6(9)):e012054 doi:10.1136/bmjopen-2016-012054.

Differentiating lower motor neuron syndromes.

Garg N, Park SB, Vucic S, et al.

Journal of neurology, neurosurgery, and psychiatry 2017; (88(6)):474-483 doi:10.1136/jnnp-2016-313526.

Fixed dynamometry is more sensitive than vital capacity or ALS rating scale.

Andres PL, Allred MP, Stephens HE, et al.

Muscle & nerve 2017; (56(4)):710-715 doi:10.1002/mus.25586.

Motor neuropathies and lower motor neuron syndromes.

Verschueren A

Revue neurologique 2017; (173(5)):320-325 doi:10.1016/j.neurol.2017.03.018.

Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria.

Cortés-Vicente E, Pradas J, Marín-Lahoz J, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2017; (18(5-6)):333-340 doi:10.1080/21678421.2017.1316408.

Adult-onset spinal muscular atrophy: An update.

Juntas Morales R, Pageot N, Taieb G, Camu W

Revue neurologique 2017; (173(5)):308-319 doi:10.1016/j.neurol.2017.03.015.

Amyotrophic lateral sclerosis or not: Keys for the diagnosis.

Lenglet T, Camdessanché JP

Revue neurologique 2017; (173(5)):280-287 doi:10.1016/j.neurol.2017.04.003.

Kennedy disease (X-linked recessive bulbospinal neuronopathy): A comprehensive review from pathophysiology to therapy.

Querin G, Sorarù G, Pradat PF

Revue neurologique 2017; (173(5)):326-337 doi:10.1016/j.neurol.2017.03.019.

Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.

Burkhardt C, Neuwirth C, Sommacal A, et al.

PloS one 2017; (12(5)):e0177555 doi:10.1371/journal.pone.0177555.

[Healing of Amyotrophic Lateral Sclerosis: A Case Report].

Mangelsdorf I, Walach H, Mutter J

Complementary medicine research 2017; (24(3)):175-181 doi:10.1159/000477397.

Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: A scoping review.

Oh J, Kim JA

Journal of clinical nursing 2017; (26(23-24)):4129-4152 doi:10.1111/jocn.13945.

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.

Radunovic A, Annane D, Rafiq MK, et al.

The Cochrane database of systematic reviews 2017; (10()):CD004427 doi:10.1002/14651858.CD004427.pub4.

End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease.

Cheng HWB, Chan OMI, Chan CHR, et al.

The American journal of hospice & palliative care 2018; (35(6)):847-851 doi:10.1177/1049909117735832.

[Analysis of the clinical and electrophysiological characteristics of multifocal motor neuropathy].

Wang HF, Yang F, Cui F, et al.

Zhonghua nei ke za zhi 2017; (56(11)):842-845 doi:10.3760/cma.j.issn.0578-1426.2017.11.013.

Supportive & palliative interventions in motor neurone disease: what we know from current literature?

Cheng HWB, Chan KY, Chung YKJ, et al.

Annals of palliative medicine 2018; (7(3)):320-331 doi:10.21037/apm.2017.10.01.

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis.

Hinchcliffe M, Smith A

Degenerative neurological and neuromuscular disease 2017; (7()):61-70 doi:10.2147/DNND.S135748.

Cognitive and behavioural changes in PLS and PMA:challenging the concept of restricted phenotypes.

de Vries BS, Rustemeijer LMM, Bakker LA, et al.

Journal of neurology, neurosurgery, and psychiatry 2019; (90(2)):141-147 doi:10.1136/jnnp-2018-318788.

Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis.

Volk AE, Weishaupt JH, Andersen PM, et al.

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 2018; (30(2)):252-258 doi:10.1007/s11825-018-0185-3.

Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.

Wei QQ, Chen Y, Chen X, et al.

Brain research bulletin 2018; (142()):403-408 doi:10.1016/j.brainresbull.2018.09.005.

Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review.

Querin G, Bede P, Marchand-Pauvert V, Pradat PF

Frontiers in neurology 2018; (9()):844 doi:10.3389/fneur.2018.00844.

Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R.

Jackson C, De Carvalho M, Genge A, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2018; (19(7-8)):506-512 doi:10.1080/21678421.2018.1497658.

Evaluation of remote pulmonary function testing in motor neuron disease.

Geronimo A, Simmons Z

Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(5-6)):348-355 doi:10.1080/21678421.2019.1587633.

Assessing Inspiratory Muscle Strength for Early Detection of Respiratory Failure in Motor Neuron Disease: Should We Use MIP, SNIP, or Both?

Janssens JP, Adler D, Iancu Ferfoglia R, et al.

Respiration; international review of thoracic diseases 2019; (98(2)):114-124 doi:10.1159/000498972.

Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.

Baxter SK, Johnson M, Clowes M, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(7-8)):461-472 doi:10.1080/21678421.2019.1627372.

Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.

van der Burgh HK, Westeneng HJ, Meier JM, et al.

NeuroImage. Clinical 2019; (24()):101984 doi:10.1016/j.nicl.2019.101984.

The Natural History of Cervical Spondylotic Myelopathy and Ossification of the Posterior Longitudinal Ligament: A Review Article.

Aljuboori Z, Boakye M

Cureus 2019; (11(7)):e5074 doi:10.7759/cureus.5074.

The revised El Escorial criteria "clinically probable laboratory supported ALS"-once a promising now a superfluous category?

Braun N, Macklin EA, Sinani E, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(1-2)):24-28 doi:10.1080/21678421.2019.1666875.

Psychological distress in partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: what's the role of care demands and perceived control?

de Wit J, Beelen A, van den Heerik MS, et al.

Psychology, health & medicine 2020; (25(3)):319-330 doi:10.1080/13548506.2019.1686646.

Pre-symptomatic diagnosis in ALS.

Corcia P, Lumbroso S, Cazeneuve C, et al.

Revue neurologique 2020; (176(3)):166-169 doi:10.1016/j.neurol.2019.07.027.

Predictive factors for gastrostomy at time of diagnosis and impact on survival in patients with amyotrophic lateral sclerosis.

Vergonjeanne M, Fayemendy P, Marin B, et al.

Clinical nutrition (Edinburgh, Scotland) 2020; (39(10)):3112-3118 doi:10.1016/j.clnu.2020.01.018.

The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Pradat PF, Bernard E, Corcia P, et al.

Orphanet journal of rare diseases 2020; (15(1)):90 doi:10.1186/s13023-020-01366-z.

[Calculation of the prevalence of progressive muscular atrophy among adults in China based on urban medical insurance data from 15 provinces].

Xu L, Chen L, Fan DS, et al.

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2020; (52(3)):521-526 doi:10.19723/j.issn.1671-167X.2020.03.019.

Metabolic alterations in spinal and bulbar muscular atrophy.

Francini-Pesenti F, Vitturi N, Tresso S, Sorarù G

Revue neurologique 2020; (176(10)):780-787 doi:10.1016/j.neurol.2020.03.020.

Requested withdrawal of gastrostomy feeding in motor neurone disease.

Wakefield D, Hanson SR

BMJ supportive & palliative care 2023; (13(e1)):e88-e90 doi:10.1136/bmjspcare-2020-002428.

Evaluation of Dysphagia in Motor Neuron Disease. Review of Available Diagnostic Tools and New Perspectives.

Romero-Gangonells E, Virgili-Casas MN, Dominguez-Rubio R, et al.

Dysphagia 2021; (36(4)):558-573 doi:10.1007/s00455-020-10170-7.

Amyotrophic lateral sclerosis: update on clinical management.

Norris SP, Likanje MN, Andrews JA

Current opinion in neurology 2020; (33(5)):641-648 doi:10.1097/WCO.0000000000000864.

Safety of Gastrostomy Tube Placement in Patients with Advanced Amyotrophic Lateral Sclerosis With Noninvasive Ventilation.

Kim EY, Kang SW, Suh MR, et al.

JPEN. Journal of parenteral and enteral nutrition 2021; (45(6)):1338-1346 doi:10.1002/jpen.2018.

Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: the 'split-leg' sign.

Min YG, Choi SJ, Hong YH, et al.

Scientific reports 2020; (10(1)):15661 doi:10.1038/s41598-020-72887-7.

Electrodiagnosis of Amyotrophic Lateral Sclerosis: A Review of Existing Guidelines.

de Carvalho M

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2020; (37(4)):294-298 doi:10.1097/WNP.0000000000000682.

Degenerative Cervical Myelopathy: Recognition and Management.

Kane SF, Abadie KV, Willson A

American family physician 2020; (102(12)):740-750.

The cutaneous silent period in motor neuron disease.

Castro J, Swash M, de Carvalho M

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(2)):660-665 doi:10.1016/j.clinph.2020.10.033.

The Benefit of Non-invasive Ventilation in Motor Neuron Disease.

Walsh LJ, Murphy DM

The open respiratory medicine journal 2020; (14()):53-61 doi:10.2174/1874306402014010053.

Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis.

de Almeida FEO, do Carmo Santana AK, de Carvalho FO

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(3)):911-923 doi:10.1007/s10072-020-05011-2.

An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials.

van Eijk RPA, de Jongh AD, Nikolakopoulos S, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(3-4)):300-307 doi:10.1080/21678421.2021.1879865.

Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.

Barceló MA, Povedano M, Vázquez-Costa JF, et al.

Scientific reports 2021; (11(1)):6207 doi:10.1038/s41598-021-85395-z.

Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.

Van Nguyen T, Tran TA, Vu HT

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(1)):393-398 doi:10.1007/s10072-021-05333-9.

Relative effects of forced vital capacity and ALSFRS-R on survival in ALS.

Daghlas SA, Govindarajan R,

Muscle & nerve 2021; (64(3)):346-351 doi:10.1002/mus.27344.

SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis.

Bos JW, Groen EJN, Wadman RI, et al.

Neurology. Genetics 2021; (7(4)):e598 doi:10.1212/NXG.0000000000000598.

Gold Coast diagnostic criteria increase sensitivity in amyotrophic lateral sclerosis.

Pugdahl K, Camdessanché JP, Cengiz B, et al.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2021; (132(12)):3183-3189 doi:10.1016/j.clinph.2021.08.014.

Electrodiagnostic Assessment of Motor Neuron Disease.

Kang X, Quan D

Neurologic clinics 2021; (39(4)):1071-1081 doi:10.1016/j.ncl.2021.06.008.

Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review.

Pinto WBVR, Souza PVS, Badia BML, et al.

Arquivos de neuro-psiquiatria 2021; (79(10)):912-923 doi:10.1590/0004-282X-ANP-2020-0429.

Caregivers' View of Socio-Medical Care in the Terminal Phase of Amyotrophic Lateral Sclerosis-How Can We Improve Holistic Care in ALS?

Linse K, Aust E, Günther R, Hermann A

Journal of clinical medicine 2022; (11(1)) doi:10.3390/jcm11010254.

Comparative Performance of Different Respiratory Test Parameters for Detection of Early Respiratory Insufficiency in Patients With ALS.

Kelly CR, Parra-Cantu C, Thapa P, et al.

Neurology 2022; (99(7)):e743-e750 doi:10.1212/WNL.0000000000200758.

Oropharyngeal Dysphagia as the Main Expression of Amyotrophic Lateral Sclerosis.

Rugaitienė M, Damulevičienė G, Lesauskaitė V, Ulozienė I

Medicina (Kaunas, Lithuania) 2022; (58(5)) doi:10.3390/medicina58050647.

Characterising ALS disease progression according to El Escorial and Gold Coast criteria.

de Jongh AD, Braun N, Weber M, et al.

Journal of neurology, neurosurgery, and psychiatry 2022; (93(8)):865-870 doi:10.1136/jnnp-2022-328823.

MND Phenotypes Differentiation: The Role of Multimodal Characterization at the Time of Diagnosis.

Meo G, Ferraro PM, Cillerai M, et al.

Life (Basel, Switzerland) 2022; (12(10)) doi:10.3390/life12101506.

Rapidly and slowly progressive neuromuscular disease: differences in pulmonary function, respiratory tract infections and response to lung volume recruitment therapy (LVR).

Sheers NL, Berlowitz DJ, Dirago RK, et al.

BMJ open respiratory research 2022; (9(1)) doi:10.1136/bmjresp-2022-001241.

An SPG7 mutation as a novel cause of monogenic progressive muscular atrophy.

Pereira Â, Tkachenko N, Fortuna AM, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(9)):3303-3305 doi:10.1007/s10072-023-06867-w.

Guideline "Motor neuron diseases" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie).

Petri S, Grehl T, Grosskreutz J, et al.

Neurological research and practice 2023; (5(1)):25 doi:10.1186/s42466-023-00251-x.

Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS.

McCluskey G, Morrison KE, Donaghy C, et al.

Life (Basel, Switzerland) 2023; (13(6)) doi:10.3390/life13061301.

Slowly progressive late-onset spinal muscular atrophy Finkel-type related to p.Pro56Ser VABP mutation in Colombia.

Correa-Arrieta C, Ortiz-Corredor F, Castellar-Leones S, Sánchez-Peñarete D

Amyotrophic lateral sclerosis & frontotemporal degeneration 2023; (24(7-8)):763-765 doi:10.1080/21678421.2023.2241881.

Accessing and Receiving Speech-Language Pathology Services at the Multidisciplinary Amyotrophic Lateral Sclerosis Clinic: An Exploratory Qualitative Study of Patient Experiences and Needs.

Huynh A, Adams K, Barnett-Tapia C, et al.

Journal of speech, language, and hearing research : JSLHR 2024; (67(10S)):4025-4037 doi:10.1044/2023_JSLHR-23-00087.

Temporal course of cognitive and behavioural changes in motor neuron diseases.

McHutchison CA, Wuu J, McMillan CT, et al.

Journal of neurology, neurosurgery, and psychiatry 2024; (95(4)):316-324 doi:10.1136/jnnp-2023-331697.

Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects.

Hoxhaj P, Hastings N, Kachhadia MP, et al.

Cureus 2023; (15(9)):e45489 doi:10.7759/cureus.45489.

Characteristics of Sensory Neuron Dysfunction in Amyotrophic Lateral Sclerosis (ALS): Potential for ALS Therapy.

Seki S, Kitaoka Y, Kawata S, et al.

Biomedicines 2023; (11(11)) doi:10.3390/biomedicines11112967.

A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy.

Allen JA, Clarke AE, Harbo T

Mayo Clinic proceedings. Innovations, quality & outcomes 2024; (8(1)):74-81 doi:10.1016/j.mayocpiqo.2023.12.002.

Degenerative Cervical Myelopathy: A Concept Review and Clinical Approach.

Gallagher DO, Taghlabi KM, Bondar K, Saifi C

Clinical spine surgery 2024; (37(1)):1-8 doi:10.1097/BSD.0000000000001463.

Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.

Cantara S, Simoncelli G, Ricci C

International journal of molecular sciences 2024; (25(9)) doi:10.3390/ijms25094809.

[Electrodiagnostic support in an atypical form of amyotrophic lateral sclerosis (Vulpian-Bernhardt syndrome)].

Aguilar-Vázquez CA, Aguilar-Castillo SJ, Raymundo-Carrillo AD

Revista medica del Instituto Mexicano del Seguro Social 2024; (62(1)):1-8.

Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis.

Jimenez JV, Tang MJ, Wilson MW, et al.

Muscle & nerve 2024; (70(5)):1099-1103 doi:10.1002/mus.28250.

Motor Neuron Diseases and Central Nervous System Tractopathies: Clinical-Radiologic Correlation and Diagnostic Approach.

Desai AB, Agarwal A, Mohamed AS, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(1)):e240067 doi:10.1148/rg.240067.

Degenerative Cervical Myelopathy: History, Physical Examination, and Diagnosis.

Balmaceno-Criss M, Singh M, Daher M, et al.

Journal of clinical medicine 2024; (13(23)) doi:10.3390/jcm13237139.

Multifocal Motor Neuropathy: A Narrative Review.

Claytor B, Polston D, Li Y

Muscle & nerve 2025; (71(4)):512-534 doi:10.1002/mus.28349.

Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunction.

Meyer T, Boentert M, Großkreutz J, et al.

Neurological research and practice 2025; (7(1)):27 doi:10.1186/s42466-025-00389-w.

Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study.

van Eijk RPA, Weemering DN, Opie-Martin S, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2025; (26(sup1)):30-40 doi:10.1080/21678421.2024.2443985.

Multiple System Atrophy (Cerebellar Type) With Overlapping Progressive Muscular Atrophy Features and Genetic Erb-B2 Receptor Tyrosine Kinase 4 (ERBB4) Amyotrophic Lateral Sclerosis Variant: A Case Report.

Panganiban ELC, Rosales RL

Cureus 2025; (17(4)):e82509 doi:10.7759/cureus.82509.

Early assessment in bulbar-onset amyotrophic lateral sclerosis detects similar rates of nocturnal desaturation and orthopnoea compared to non-bulbar-onset disease.

Luu S, McGuiness OA, Menadue C, et al.

Sleep & breathing = Schlaf & Atmung 2025; (30(1)):3.

A 10-year service evaluation of a multidisciplinary neuro-palliative care model in motor neuron disease: Impact on palliative care service delivery & advance care planning.

Chung WKV, Chan KP, Hsu DY, et al.

Palliative medicine 2025; 2692163251396020 doi:10.1177/02692163251396020.

Mortality and Complications of Percutaneous Gastrostomy in Amyotrophic Lateral Sclerosis Patients.

Dallaire JS, Bachand MP, Shaul J, Lareau-Trudel E

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2026; 1-8 doi:10.1017/cjn.2025.10510.

Current and Ongoing Clinical Studies.

Abrahao A, Zinman L, Apple S

Muscle & nerve 2026; (73 Suppl 1()):S26-S28 doi:10.1002/mus.70040.

[Motor neuron diseases from a radiological perspective : Focus on amyotrophic lateral sclerosis].

Warmann S

Radiologie (Heidelberg, Germany) 2026; (66(4)):272-277 doi:10.1007/s00117-026-01577-8.

ALS motor phenotypes: a revised 'OPM' classification.

Meyer T, Ticozzi N, Weber M, et al.

Amyotrophic lateral sclerosis & frontotemporal degeneration 2026; (27(5-6)):540-552 doi:10.1080/21678421.2026.2644277.

Anterior Horn Cell Disease in Adulthood: Unmasking Spinal Muscular Atrophy Type 4.

Rafique S, Odeh A

Cureus 2026; (18(3)):e105356 doi:10.7759/cureus.105356.

Revisiting multifocal motor neuropathy: mechanisms, diagnosis and future directions.

Dubuisson NJ, Rajabally YA, Philips C, et al.

Brain : a journal of neurology 2026; doi:10.1093/brain/awag260.

Amyotrophic lateral sclerosis and degenerative cervical myelopathy: phenotype-based diagnostic pitfalls, investigative mismatch, and practical clinical reasoning.

Chen D, Shen T, Ren H, Qiu P

Frontiers in neurology 2026; (17()):1901811 doi:10.3389/fneur.2026.1901811.

Emergencies in Amyotrophic Lateral Sclerosis.

Uysal SP, Dudley KA, Sullivan S, et al.

Muscle & nerve 2026; doi:10.1002/mus.70398.

When Hypercapnia Misleads: A Case of Respiratory-Onset Motor Neuron Disease.

Kordi Y, Ismail M, Estabrook E

Cureus 2026; (18(10)):e117375 doi:10.7759/cureus.117375.